TherapeuticsMD Inc reports results for the quarter ended in March - Earnings Summary

TherapeuticsMD

16/05/2023 17:43

* TherapeuticsMD Inc  TXMD.OQ  reported a quarterly adjusted
loss
of 37 cents​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for earnings of 6 cents per
share.
    * Revenue fell 97.8% to $416.00 thousand from a year ago;
analysts
expected $1.70 million. 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * TherapeuticsMD Inc shares had risen by 17.1% this
quarter and
lost 21.5% so far this year.
    * Wall Street's median 12-month price target for
TherapeuticsMD
Inc is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
16 at 04:43 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      0.06           -0.37          Missed
 Dec. 31 2022      -1.11          8.23           Beat
 Sep. 30 2022      -0.57          -3.13          Missed
 Jun. 30 2022      -3.04          12.39          Beat